Delivery Order SPE2DB22D1041-SPE2DB23FP6QT
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,517.47, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to manage diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,933.12, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication used to treat diabetes. The contract is a firm fixed-price, delivery order type with an ultimate completion date of April 3, 2023. This award is not associated with a set-aside program. The contract is part of a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,120.88, is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract is a Firm Fixed Price (FFP) delivery order, with a period of performance through March 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication used for the treatment of diabetes. The contract has a ceiling value of $1,537.64 and a period of performance through July 15, 2024. This order was placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.76, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract is a firm fixed-price delivery order, with a period of performance through July 16, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
- This is a $1,837.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides global pharmaceutical support to...
- This federal contract award, valued at $1,173.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used in the treatment of diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is a delivery order valued at $1,022.80 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 29, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a $4,613.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. The award has an ultimate completion date of July 7, 2025. While this appears to be an individual delivery order, Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB23FP6QTDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,229.56, is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. The contract has a period of performance through September 2023 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award was not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/21/23 |